View Future GrowthNovoray 과거 순이익 실적과거 기준 점검 3/6Novoray은 연평균 14.7%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 5.6% 감소했습니다. 매출은 연평균 16.3%의 비율로 증가했습니다. Novoray의 자기자본이익률은 16.5%이고 순이익률은 25.7%입니다.핵심 정보14.67%순이익 성장률14.62%주당순이익(EPS) 성장률Chemicals 산업 성장률12.10%매출 성장률16.29%자기자본이익률16.46%순이익률25.73%다음 순이익 업데이트15 Aug 2026최근 과거 실적 업데이트공고 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026공고 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026공고 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026공고 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025공고 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025공고 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025모든 업데이트 보기Recent updates공고 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Apr 21Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China공고 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026공고 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026공고 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025공고 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025공고 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China공고 • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.공고 • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공고 • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.공고 • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu ChinaReported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역Novoray가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이XSSC:688300 매출, 비용 및 순이익 (CNY Millions)날짜매출순이익일반관리비연구개발비31 Mar 261,171301756631 Dec 251,116293716430 Sep 251,090287706530 Jun 251,036273686131 Mar 25997263676131 Dec 24960251676030 Sep 24895234665630 Jun 24841218655531 Mar 24769197615131 Dec 23712174594730 Sep 23685182604530 Jun 23625169573931 Mar 23630174553831 Dec 22662188513830 Sep 22657175473830 Jun 22686186454031 Mar 22663179463831 Dec 21625173463530 Sep 21581169493030 Jun 21522147492631 Mar 21473130442431 Dec 20404111442030 Sep 2036792461930 Jun 2034182451631 Mar 2032178501331 Dec 1931575481330 Sep 1929869431230 Jun 1929267411231 Mar 1927760381131 Dec 1827858381130 Sep 1826454371030 Jun 1824950371031 Mar 182304634931 Dec 172114232830 Sep 171934131630 Jun 171763931331 Mar 171653632231 Dec 161543333030 Sep 161432732030 Jun 161322031031 Mar 161271930031 Dec 151221830030 Sep 1512119290양질의 수익: 688300는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 688300의 현재 순 이익률 (25.7%)은 지난해 (26.4%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 688300의 수익은 지난 5년 동안 연평균 14.7% 증가했습니다.성장 가속화: 지난 1년간 688300 의 수익 증가율(14.7%)은 5년 평균(연간 14.7%)보다 낮습니다.수익 대 산업: 688300의 지난 1년 수익 증가율(14.7%)은 Chemicals 업계의 3.7%를 상회했습니다.자기자본이익률높은 ROE: 688300의 자본 수익률(16.5%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/23 11:34종가2026/07/23 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Novoray Corporation는 3명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yilin HouChina International Capital Corporation LimitedChao LiCitic Securities Co., Ltd.Wei LiuHaitong International Research Limited
공고 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026
공고 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
공고 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
공고 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
공고 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025
공고 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
공고 • Jun 30Novoray Corporation to Report First Half, 2026 Results on Aug 15, 2026Novoray Corporation announced that they will report first half, 2026 results on Aug 15, 2026
Declared Dividend • Jun 06Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 0.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (40% earnings payout ratio) but not adequately covered by cash flows (91% cash payout ratio). The dividend has increased by an average of 19% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 38% over the next year, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Fan Wu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Apr 21Novoray Corporation, Annual General Meeting, May 18, 2026Novoray Corporation, Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: 2F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
공고 • Mar 30Novoray Corporation to Report Q1, 2026 Results on Apr 28, 2026Novoray Corporation announced that they will report Q1, 2026 results on Apr 28, 2026
공고 • Dec 26Novoray Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026Novoray Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
공고 • Sep 30Novoray Corporation to Report Q3, 2025 Results on Oct 30, 2025Novoray Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
공고 • Jun 30Novoray Corporation to Report First Half, 2025 Results on Aug 27, 2025Novoray Corporation announced that they will report first half, 2025 results on Aug 27, 2025
공고 • Mar 28Novoray Corporation to Report Q1, 2025 Results on Apr 29, 2025Novoray Corporation announced that they will report Q1, 2025 results on Apr 29, 2025
공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 17, 2025Novoray Corporation, Annual General Meeting, Apr 17, 2025, at 14:00 China Standard Time. Location: 3F, Comprehensive Building, No. 6, Zhujiang Road, Xinpu Economic Development Zone, Haizhou District, Lianyungang, Jiangsu China
공고 • Dec 27Novoray Corporation to Report Fiscal Year 2024 Results on Mar 26, 2025Novoray Corporation announced that they will report fiscal year 2024 results on Mar 26, 2025
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥57.50, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 23% over the past year.
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.37 (up from CN¥0.28 in 3Q 2023). Revenue: CN¥250.4m (up 27% from 3Q 2023). Net income: CN¥67.4m (up 30% from 3Q 2023). Profit margin: 27% (in line with 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
공고 • Sep 30Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024Novoray Corporation announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥44.57, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 4.8% over the past year.
Reported Earnings • Aug 26Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.23 in 2Q 2023). Revenue: CN¥241.1m (up 43% from 2Q 2023). Net income: CN¥65.8m (up 49% from 2Q 2023). Profit margin: 27% (up from 26% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공고 • Jun 28Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024Novoray Corporation announced that they will report first half, 2024 results on Aug 26, 2024
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.28 (up from CN¥0.15 in 1Q 2023). Revenue: CN¥202.3m (up 40% from 1Q 2023). Net income: CN¥51.7m (up 80% from 1Q 2023). Profit margin: 26% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China.
공고 • Mar 29Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024Novoray Corporation announced that they will report Q1, 2024 results on Apr 26, 2024
공고 • Mar 26Novoray Corporation, Annual General Meeting, Apr 19, 2024Novoray Corporation, Annual General Meeting, Apr 19, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Lianyungang, Jiangsu China
Reported Earnings • Mar 26Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥1.01 in FY 2022)Full year 2023 results: EPS: CN¥0.94 (down from CN¥1.01 in FY 2022). Revenue: CN¥711.7m (up 7.5% from FY 2022). Net income: CN¥174.0m (down 7.6% from FY 2022). Profit margin: 24% (down from 28% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥35.60, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 13x in the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥57.99, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 16x in the Chemicals industry in China.
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.21 in 3Q 2022). Revenue: CN¥196.7m (up 43% from 3Q 2022). Net income: CN¥51.8m (up 33% from 3Q 2022). Profit margin: 26% (down from 28% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 19Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.26 in 2Q 2022). Revenue: CN¥169.1m (down 2.4% from 2Q 2022). Net income: CN¥44.3m (down 11% from 2Q 2022). Profit margin: 26% (down from 29% in 2Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Buying Opportunity • Aug 11Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥53.21, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 76% in 2 years. Earnings is forecast to grow by 94% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥51.75, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 16x in the Chemicals industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥44.12 per share.
Reported Earnings • May 02First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.23 (down from CN¥0.34 in 1Q 2022). Revenue: CN¥145.0m (down 18% from 1Q 2022). Net income: CN¥28.7m (down 33% from 1Q 2022). Profit margin: 20% (down from 24% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 32%After last week's 32% share price gain to CN¥87.58, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Chemicals industry in China.
Board Change • Mar 15Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Dong Hui Pan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.